Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ambrosia Bio logo — We are forging a healthier world, one rare sugar at a time.

Ambrosia Bio

We are forging a healthier world, one rare sugar at a time.

Founded 2020 Israel Israel 8 employees Biotechnology, Food and Beverage +1

General Information

Company Name Ambrosia Bio
Founded Year 2020
Location Israel Israel
Employees 8
Industries Biotechnology, Food and Beverage, Nutrition
Business Model B2B, White Label
Revenue Model Product Sales, Licensing, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Ambrosia Bio. To contact Ambrosia Bio, visit ambrosia.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ambrosia Bio compare?

A PDF of Ambrosia Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ambrosia Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ambrosia Bio

Ambrosia Bio, founded in 2020 and headquartered in Israel, is making noteworthy strides in the Biotechnology, Food and Beverage, and Nutrition industries.

Their slogan, "We are forging a healthier world, one rare sugar at a time," reflects their mission to revolutionize sugar consumption. Utilizing a disruptive enzyme technology platform, Ambrosia Bio designs superior enzymes that convert high-calorie industrial sugars into rare, minimal-calorie sugars. This capability addresses the growing consumer demand for sugar reduction while preserving taste, positioning them as an attractive partner to major sugar and juice manufacturers.

Their B2B model focuses on delivering tailored plug-and-play engineering solutions to meet the rising demand for Allulose. Their latest financial backing, an unknown investment from Space-F on 01 March 2023, underscores investor confidence in their technology and market potential, further strengthening their market position.

Business keywords: Rare Sugars, Enzyme Technology, Healthier Sweeteners, Sugar Conversion, B2B Sugar Solutions, Food Technology, Sugar Reduction, Allulose Production, Industrial Sugars, Plug and Play Solutions, Sugar & Juice Manufacturing, Calorie Reduction, Bioengineering, Obesity Prevention, Custom Enzyme Design

Services & Products

Production of Allulose
Development of Rare Sugar Solutions
End-to-End Sweetener Solutions

Target Customers

Food and Beverage Companies Health-Conscious Consumers Diabetic Patients Nutrition and Wellness Brands

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Round Undisclosed 1
Space-F
01 Mar 2023

Ambrosia Bio Alternatives & Competitors

Ambrosia Bio vs
INCREDIBLE® (formerly JuiceInnov8)
INCREDIBLE® (formerly JuiceInnov8) Thailand

Building the next generation of food & beverage that are healthier for everyone and greater for this...

Venture round
18 employees
Biotechnology, Food and Beverage
Ambrosia Bio vs
Sweegen
Sweegen United States

Well. Into The Future.

Series A
38 employees
Food and Beverage, Manufacturing

FAQ About Ambrosia Bio

We are forging a healthier world, one rare sugar at a time.
Ambrosia Bio was founded in 2020.
Ambrosia Bio is headquartered in Israel.
Ambrosia Bio operates in Biotechnology, Food and Beverage and Nutrition. Its work centres on Rare Sugars, Enzyme Technology, Healthier Sweeteners and Sugar Conversion. Its customers include Food and Beverage Companies, Health-Conscious Consumers and Diabetic Patients.
Ambrosia Bio has a B2B and White Label business model. Its revenue comes from Product Sales, Licensing and Project Based.
Ambrosia Bio has approximately 8 employees.
Ambrosia Bio has completed 1 funding round.
Ambrosia Bio offers: Production of Allulose, Development of Rare Sugar Solutions, End-to-End Sweetener Solutions.
Top alternatives and competitors to Ambrosia Bio include INCREDIBLE® (formerly JuiceInnov8), Sweegen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ambrosia Bio and INCREDIBLE® (formerly JuiceInnov8) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ambrosia Bio, https://bouncewatch.com/company/ambrosia-bio, updated 30 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout